Recruiting at 1 site No phase Tinnitus Aggravated

Clinical trial for Tinnitus Aggravated

Official title Non-Invasive Neurofeedback Training to Alleviate Tinnitus Distress

ClinicalTrials.gov ID: NCT07788638

What this study is testing

What it's testing
The study aims to find out if a specific type of brain training can improve emotional and mental well-being for people with bothersome tinnitus. It also looks at how brain activity changes during the treatment.
Who it's for
The study is looking for people who have tinnitus that causes them significant distress.
What's involved
Participants will undergo brain scans and complete behavioral tests before, during, and after the training. They will also receive non-invasive neurofeedback training, which helps the brain regulate its own activity.
Time commitment
The source text does not specify the total duration of the study or the number of visits required.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 70

You may be able to join if

  • Non-pulsatile tinnitus for at least 6 months,
  • Bothersome tinnitus, based on a Tinnitus Functional Index score \> 25,
  • Normal cognitive processing abilities, based on a Montreal Cognitive Assessment score\> 25.

You likely can't join if

  • Clinically diagnosed dementia or Parkinson's disease,
  • Meniere's disease,
  • Severe physical or cognitive impairments that prevent completion of study tasks or scanning,
  • History of drug or alcohol abuse,
  • History of psychological or neurological illness, except for managed anxiety or depression,
  • Severe chronic health problems other than hearing loss or tinnitus,
See the full eligibility criteria
Who can join
  • Non-pulsatile tinnitus for at least 6 months,
  • Bothersome tinnitus, based on a Tinnitus Functional Index score \> 25,
  • Normal cognitive processing abilities, based on a Montreal Cognitive Assessment score\> 25.
What rules you out
  • Clinically diagnosed dementia or Parkinson's disease,
  • Meniere's disease,
  • Severe physical or cognitive impairments that prevent completion of study tasks or scanning,
  • History of drug or alcohol abuse,
  • History of psychological or neurological illness, except for managed anxiety or depression,
  • Severe chronic health problems other than hearing loss or tinnitus,
  • Vision that is not normal or not corrected to normal,
  • Unable to meet MRI clinical safety screening requirements (e.g., metal in the body, pregnancy, certain implantable devices).

The study team makes the final eligibility decision.

Where it is enrolling

  • Urbana, Illinois, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Urbana, Illinois, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.